Indoco Remedies provides ₹25 Crore corporate guarantee for wholly-owned subsidiary
Indoco Remedies' Directors approved a ₹25 Crore corporate guarantee for its wholly-owned subsidiary, Warren Remedies, for HDFC Bank loans, creating a contingent liability for Indoco.
The ₹25 Crores corporate guarantee represents a significant contingent liability for the company, which could impact its financial position if the subsidiary defaults.
The corporate guarantee supports the subsidiary's financing needs but simultaneously creates a contingent liability for the parent company, balancing potential benefits with financial exposure.
* The Committee of Executive Directors of Indoco Remedies Limited approved a Corporate Guarantee up to a maximum principal amount of ₹25 Crores. * This guarantee is in favor of HDFC Bank Limited for loan/credit facilities to be availed by Warren Remedies Private Limited, a wholly-owned subsidiary of Indoco Remedies. * The Committee Meeting for this approval was held on 29th October 2025, commencing at 10:30 a.m. (IST) and concluding at 11:00 a.m. (IST). * Ms. Aditi Panandikar, a Promoter of Indoco Remedies, is a director of Warren Remedies Private Limited, and the guarantee is given on an arm's length basis. * The guarantee will create a contingent liability not exceeding ₹25 Crores in the books of Indoco Remedies Limited.
What to do with a filing like this
Indoco Remedies Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indoco Remedies Limited. Read the original for the full detail.